A nurse has been charged with one count of tampering with a consumer product after allegedly replacing a nursing home resident’s prescribed oxycodone with a household cleaner. According to federal prosecutors in Massachusetts, the defendant, a 65-year-old registered nurse licensed in the state, worked at a nursing home in Amesbury. The facility provides long-term chronic care and post-acute care.
The indictment alleges that on March 31, while treating a non-verbal resident with dementia who had been prescribed liquid oxycodone, the defendant removed some of the medication from the bottle using a syringe and replaced it with a household cleaner. The oxycodone, a Schedule II controlled substance, had been produced outside Massachusetts, bringing the case under federal jurisdiction.
Prosecutors claim the defendant acted “with reckless disregard for the risk that another person would be placed in danger of death and bodily injury, and under circumstances manifesting extreme indifference to such risk.”
If convicted, the defendant faces up to 10 years in prison, three years of supervised release, and a fine of up to $250,000.
The defendant was arrested on October 31 and arraigned in federal court, where she pleaded not guilty. She was released under certain conditions, including no drug or alcohol use, no contact with the alleged victim, and no employment that provides access to prescription medications.
A follow-up court appearance is scheduled for later in November.
Compliance Perspective
Issue
Failure to ensure the safe handling and administration of controlled substances in healthcare settings poses significant risks to resident safety, facility compliance, and staff integrity. Inadequate oversight, unclear policies, or inconsistent monitoring can lead to medication errors, diversion, or contamination. The diversion of residents’ prescribed controlled medications—whether for personal use or sale—constitutes abuse, neglect, misappropriation, and fraud under both state and federal regulations. Staff involved in diversion often develop methods to conceal their actions, making detection challenging. Facilities should maintain a proactive diversion-prevention program that identifies medications most likely to be diverted, recognizes behavioral and documentation indicators that diversion may have occurred, and identifies potential signs of staff impairment.
Discussion Points
- Facilities should review, and update if necessary, their policies and procedures related to the management of controlled substances. These should clearly define responsibilities for storage, handling, administration, and documentation to ensure compliance with federal and state regulations. Policies must also include guidance on investigating discrepancies and reporting suspected tampering or diversion. Engaging experienced consultants to review policy effectiveness and provide mock survey evaluations can help identify vulnerabilities and strengthen compliance readiness.
- Ongoing education is essential to ensure that all staff understand their responsibilities in preventing, identifying, and reporting medication-related incidents. Training programs should address the proper handling of controlled substances, recognizing signs of staff impairment, and understanding the implications of medication tampering or diversion. Med-Net Academy offers three training programs in its Substance Use category, which can support staff education in these areas.
- Regularly audit controlled substance management practices to maintain oversight and ensure accurate medication tracking. Audit processes should include verification of controlled substance counts, review of medication administration records, and reconciliation of shift-to-shift documentation. Facilities may also consider engaging an external mock surveyor to conduct targeted reviews of high-risk practices or units. Objective reviews can help uncover patterns that internal teams may overlook and support early intervention efforts.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*